LightDeck Diagnostics has $11 million for its new, high-speed, way to test for COVID-19, sepsis, and heart attack

LightDeck Diagnostics, a company formed earlier this year from the merger of startups mBio and Brava Diagnostics, has raised $11 million in funding for a new high-speed COVID-19 test, according to a statement.


The company’s novel test uses planar wave guide technologies to rapidly assess the presence of specific pathogens in a patient.


After collecting a patient sample, a user places the...